Cirtran Corp. (CIRX) intrinsic value & 10-year financials
Cirtran Corp. (CIRX) has a Graham intrinsic value of $136.18 per share. At $0.02 on Oct 17, 2026, the stock trades 100% below that value. Over the last 10 fiscal years revenue grew 99.4% a year to $3.1M, with an average return on invested capital of 1.8%.
- Graham intrinsic value
- $136.18
- Share price (Oct 17, 2026)
- $0.02
- Price vs Graham value
- 100% below
- Market cap
- $122.6K
- Revenue (FY2025)
- $3.1M
- Revenue growth (10-yr CAGR)
- 99.4%
- ROIC (10-yr avg)
- 1.8%
- Free cash flow (FY2025)
- —
CIRX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $3.1M | -$701.6K | -$0.14 | — | -4.1% | 2.8% |
| FY2024 | $1.3M | -$2.6M | -$0.53 | — | -42.5% | 2.3% |
| FY2023 | $1.6M | $20.3M | $4.10 | -$81.0K | -0.9% | 0.0% |
| FY2022 | $1.7M | -$1.5M | -$0.01 | — | -30.4% | 1.2% |
| FY2021 | $2.9M | $126.2K | $0.00 | $340.7K | -7.8% | -0.3% |
| FY2020 | $1.7M | $532.1K | $0.00 | $445.7K | 4.5% | -1.3% |
| FY2019 | — | -$1.2M | -$0.01 | — | — | 3.2% |
| FY2018 | — | -$1.1M | — | — | — | 2.9% |
| FY2017 | $12.5K | -$2.0M | — | — | -6345.6% | 5.2% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
CIRTRAN CORP revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
CIRTRAN CORP has historically struggled to out-earn its cost of capital, averaging just 1.8% ROIC.
CIRTRAN CORP capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, CIRTRAN CORP is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $136.18 per share.